Shanghai Allist Pharmaceuticals Co. Ltd. A - Asset Resilience Ratio

Latest as of March 2026: 21.11%

Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) has an Asset Resilience Ratio of 21.11% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688578 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥1.81 Billion

≈ $265.26 Million USD Cash + Short-term Investments

Total Assets

CN¥8.59 Billion

≈ $1.26 Billion USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Shanghai Allist Pharmaceuticals Co. Ltd. A's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Shanghai Allist Pharmaceuticals Co. Ltd. total assets.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Allist Pharmaceuticals Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 688578 total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.81 Billion	21.11%
Total Liquid Assets	CN¥1.81 Billion	21.11%

Asset Resilience Insights

Good Liquidity Position: Shanghai Allist Pharmaceuticals Co. Ltd. A maintains a healthy 21.11% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Shanghai Allist Pharmaceuticals Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Shanghai Allist Pharmaceuticals Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Xizang Haisco Pharmaceutical Group Co Ltd SHE:002653	Biotechnology	1.69%
SOLENO THERAPEUT. DL-001 F:6XC	Biotechnology	41.74%
Zhejiang Ausun Pharmaceutical Co Ltd SHG:603229	Biotechnology	0.12%
R&G PharmaStudies Co. Ltd. A SHE:301333	Biotechnology	23.94%
ChemPartner PharmaTech Co Ltd SHE:300149	Biotechnology	1.67%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Yantai Zhenghai Bio-Tech Co Ltd SHE:300653	Biotechnology	59.25%

Annual Asset Resilience Ratio for Shanghai Allist Pharmaceuticals Co. Ltd. A (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Shanghai Allist Pharmaceuticals Co. Ltd. A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	31.77%	CN¥2.51 Billion ≈ $367.44 Million	CN¥7.90 Billion ≈ $1.16 Billion	-14.87pp
2024-12-31	46.64%	CN¥2.76 Billion ≈ $403.77 Million	CN¥5.92 Billion ≈ $865.72 Million	+37.05pp
2023-12-31	9.59%	CN¥419.60 Million ≈ $61.40 Million	CN¥4.38 Billion ≈ $640.42 Million	-35.93pp
2022-12-31	45.52%	CN¥1.57 Billion ≈ $229.27 Million	CN¥3.44 Billion ≈ $503.70 Million	-6.38pp
2021-12-31	51.90%	CN¥1.62 Billion ≈ $237.74 Million	CN¥3.13 Billion ≈ $458.06 Million	-22.60pp
2020-12-31	74.50%	CN¥2.23 Billion ≈ $325.66 Million	CN¥2.99 Billion ≈ $437.10 Million	+32.77pp
2019-12-31	41.73%	CN¥554.40 Million ≈ $81.13 Million	CN¥1.33 Billion ≈ $194.39 Million	--

pp = percentage points

About Shanghai Allist Pharmaceuticals Co. Ltd. A

SHG:688578 China Biotechnology

Market Cap

$6.86 Billion

CN¥46.90 Billion CNY

Market Cap Rank

#2916 Global

#360 in China

Share Price

CN¥104.22

Change (1 day)

-7.29%

52-Week Range

CN¥80.02 - CN¥133.00

All Time High

CN¥133.00